E-LIB Suche - Ergebnisse für: Heinzerling, L.

1

Checkpoint inhibitor‐induced bullous pemphigoid differs fro..:

Kramer, N. ; Müller, G. ; Zierold, S....
Journal of the European Academy of Dermatology and Venereology. , 2024

2

Cancer of unknown primary (CUP) through the lens of precisi..:

Weiss, L. ; Heinrich, K. ; Zhang, D....
Journal of Cancer Research and Clinical Oncology. 149 (2023) 11 - p. 8225-8234 , 2023

Link: https://doi.org/10.1007/..

3

Preferences of German and Swiss melanoma patients for toxic..:

Kähler, Katharina C. ; Hüning, S. ; Nashan, D....
Journal of Cancer Research and Clinical Oncology. 149 (2023) 13 - p. 11705-11718 , 2023

Link: https://doi.org/10.1007/..

4

Evaluation of Planning Techniques Involving Inverse Optimiz..:

Laughlin, B. ; DeWees, T.A. ; Rule, W.G....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e549-e550 , 2022

Link: https://doi.org/10.1016/..

5

PO-1159 Stereotactic radiosurgery and combined immunotherap..:

Bodensohn, R. ; Werner, S. ; Reis, J....
Radiotherapy and Oncology. 170 (2022) - p. S983-S984 , 2022

Link: https://doi.org/10.1016/..

6

AUTOIMMUNE & INFLAMMATORY NMD:

Preusse, C. ; Eede, P. ; Heinzerling, L....
Neuromuscular Disorders. 31 (2021) - p. S52 , 2021

Link: https://doi.org/10.1016/..

7

Monitoring skin metastases during immuno‐ and targeted ther..:

Erdmann, M. ; Heinzerling, L. ; Schuler, G...
Journal of the European Academy of Dermatology and Venereology. 35 (2020) 1 - p. , 2020

Link: https://doi.org/10.1111/..

8

Transient response to nivolumab and relapse after inflixima..:

Toussaint, F. ; Erdmann, M. ; Grosch, E....
British Journal of Dermatology. 184 (2020) 2 - p. 345-347 , 2020

Link: https://doi.org/10.1111/..

9

Sequence-dependent cross-resistance of combined radiotherap..:

Shannan, B. ; Matschke, J. ; Chauvistré, H....
European Journal of Cancer. 109 (2019) - p. 137-153 , 2019

Link: https://doi.org/10.1016/..

10

Effective anti-programmed death-1 therapy in aSUFU-mutated ..:

Moreira, A. ; Kirchberger, M.C. ; Toussaint, F....
British Journal of Dermatology. 179 (2018) 3 - p. 747-749 , 2018

Link: https://doi.org/10.1111/..

11

Neurologische Nebenwirkungen von Checkpoint-Inhibitoren:

Knauss, S. ; Ginesta Roque, L. ; Hühnchen, P....
Der Nervenarzt. 90 (2018) 2 - p. 138-147 , 2018

Link: https://doi.org/10.1007/..

12

Predictive value of PD-L1 based on mRNA level in the treatm..:

Brüggemann, C. ; Kirchberger, M. C. ; Goldinger, S. M....
Journal of Cancer Research and Clinical Oncology. 143 (2017) 10 - p. 1977-1984 , 2017

Link: https://doi.org/10.1007/..

13

3323 The GERMELATOX DeCOG-trial: The attitude of German mel..:

Kaehler, K.C. ; Augustin, M. ; Blohme, C....
European Journal of Cancer. 51 (2015) - p. S671-S672 , 2015

Link: https://doi.org/10.1016/..

14

Reply: Intra-patient heterogeneity of BRAF mutation status:..:

Heinzerling, L ; Schuler, G ; Hartmann, A.
British Journal of Cancer. 111 (2014) 8 - p. 1679-1680 , 2014

Link: https://doi.org/10.1038/..

15

Insulin allergy:

Heinzerling, L.
Diabetic Medicine. 30 (2013) 8 - p. 891-892 , 2013

Link: https://doi.org/10.1111/..